COLORADO SPRINGS, Colo.--(BUSINESS WIRE) -- Cannabis Science Inc. (NASD OTCBB: CBIS) an emerging pharmaceutical cannabis company, reports that it has created a new Policy Advisory Board as it receives an unprecedented amount of support from various professionals wanting to advance the Company’s development of medical cannabis products. These individuals include attorneys, financial experts, and pharmaceutical manufacturing specialists. Also, the Company is expanding its Scientific Advisory Board to add more members and broaden its focus.
